Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome.
about
Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndromeToxic shock syndrome and sinusitis--a hidden site of infection.Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.pH-Dependent Antimicrobial Properties of Copper Oxide Nanoparticles in Staphylococcus aureus.Vaccination against Staphylococcus aureus pneumoniaThe innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.Staphylococcus aureus exotoxins are present in vivo in tamponsProinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics.Global repression of exotoxin synthesis by staphylococcal superantigens.Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection.Staphylococcal superantigens cause lethal pulmonary disease in rabbits.Staphylococcal and streptococcal superantigen exotoxinsInduction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndromeEnterococcus faecalis inhibits superantigen toxic shock syndrome toxin-1-induced interleukin-8 from human vaginal epithelial cells through tetramic acidsNew insights into the prevention of staphylococcal infections and toxic shock syndrome.Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines.Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.Genotypic and phenotypic analysis of clinical isolates of Staphylococcus aureus revealed production patterns and hemolytic potentials unlinked to gene profiles and source.Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock SyndromeAlpha-toxin promotes Staphylococcus aureus mucosal biofilm formation.Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expressionSynergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality.Impact of anaerobic growth conditions on toxic shock syndrome toxin-i production by Staphylococcus aureusAlpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxinsGlycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureusCharacterization of clinical strains of Staphylococcus aureus associated with pneumonia.Production of toxic-shock-associated protein(s) in Staphylococcus aureus strains isolated from 1956 through 1982.Serum antibodies to enterotoxins produced by Staphylococcus aureus with special reference to enterotoxin F and toxic shock syndromeA single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome.Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animalsToxic shock syndrome caused by suture abscess with methicillin-resistant Staphylococcus aureus (MRSA) with late onset after Caesarean section.Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases
P2860
Q24607551-96DC4097-B7BA-4E42-8DD1-BFC3702113A4Q33615635-21C8B6C0-487F-4C9C-845A-09674631C50EQ33622670-84D438A9-3B31-4669-874D-BF65B304A1A7Q33624615-15630391-5554-43C0-B4BC-1F6653E1E4B9Q33684334-5423E998-B3F5-41F6-8CD5-4E223586DF0BQ33769457-5D16BBBA-C7EB-4B29-918D-5E4D8DD6FAD2Q33825638-7196FDDF-43CB-4E27-AC39-0D4782FC9A90Q33958583-BF3133C8-3717-4E1E-BF5A-AC7AB91E5038Q34000838-9F5338D8-C8CB-456D-A51A-8ED2400EB52AQ34099174-D07796A7-09B8-4300-BFE5-C816EA8AE061Q34264762-FA075963-2943-4CCA-9D0B-1686CDE637C4Q34280083-2C137233-73DD-4413-8701-2CB70DCBE241Q34355243-6A59B70C-C54F-4102-AA3E-43DD84A02210Q34609429-166F0275-8CCB-4E2B-8C32-912E088BCE0BQ34684220-97DC2025-536B-4674-BAEF-37BF1BA5DF48Q35008802-424F6454-707E-4510-9B97-0AC8B9C6321EQ35035880-E6554D31-ADCA-46DE-9269-E9DF9B4E94F5Q35153205-EA9C56F5-F9C1-4D46-AD9F-2ECB1F786A02Q35910386-4D034068-0557-4760-B067-2F75EBB78F06Q35947504-FA9FC950-247F-4A97-BC64-35B179D3DCB6Q36077299-DE43BEDB-3CF9-4B89-A421-C823EB072615Q36158880-8ADAA485-2D3A-4674-801D-CF7D48A060D7Q36314201-D558327E-8676-47ED-B235-0AAF117D6E4CQ36338910-22C0640C-2D72-4B5B-886B-650EDDC1440EQ36625091-B37C98AF-3678-4913-8378-6E99D8256676Q36731924-F3DF350F-0590-483B-B644-60EF36A23332Q36910011-CA651103-FD21-4DF5-A17A-846FD86446C8Q37042273-A81F8458-1FD5-4B50-A702-43CB39AACD8AQ37207576-D4970D5D-6066-4B12-A7F1-EFBFF3139305Q37266257-E5874CE4-5257-457F-A8FF-47841A43622CQ37309130-95310605-35F2-42CC-A5B6-940235A094C5Q37662564-B2DEF962-19A2-4E2A-BAC8-FB21189819D4Q37953740-CFDF79C0-B82C-4A3D-8ECD-D321A6098944Q39516496-8F92C59B-F739-4ABA-B0DC-C9BE34765F2AQ40101072-DEDCE05B-29CA-4E72-9ADE-05B9F6203C2DQ40158084-9F7BECDC-613A-4CA4-86A0-5CB08F99D829Q58441832-7FE813BF-D7CA-409C-AC18-74597A5C39D5
P2860
Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@en
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@nl
type
label
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@en
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@nl
prefLabel
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@en
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@nl
P2093
P1476
Toxin and enzyme characterizat ...... without toxic shock syndrome.
@en
P2093
Nishimura RD
Osterholm MT
Schlievert PM
P304
P356
10.7326/0003-4819-96-6-937
P407
P433
P577
1982-06-01T00:00:00Z